Knockdown of macrophage migration inhibitory factor disrupts adipogenesis in 3T3-L1 cells

Endocrinology

Volumn 149, Issue 12, 2008, Pages 6037-6042

  Ikeda, Daisuke ^a   Sakaue, Shinji ^a   Kamigaki, Mitsunori ^a   Ohira, Hiroshi ^a   Itoh, Naofumi ^a   Ohtsuka, Yoshinori ^a   Tsujino, Ichizo ^a   Nishimura, Masaharu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BROMODEOXYCYTIDINE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RNA; SMALL INTERFERING RNA; TRIACYLGLYCEROL;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HYPOTHESIS; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; RNA INTERFERENCE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPONECTIN; ANIMALS; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE KNOCKDOWN TECHNIQUES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; PPAR GAMMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 57349116047     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0158     Document Type: Article

References (48)

1. Haslam DW, James WP 2005 Obesity. Lancet 366:1197-1209
2. Gregoire FM, Smas CM, Sul HS 1998 Understanding adipocyte differentiation. Physiol Rev 78:783-809
3. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ 2001 The biology of white adipocyte proliferation. Obes Rev 2:239-254
4. Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C, Rheaume C, Tchernof A 2008 Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes 32:283-291
5. Kadowaki T, Hara K, Yamauchi T, Terauchi Y, Tobe K, Nagai R 2003 Molecular mechanism of insulin resistance and obesity. Exp Biol Med 228:1111-1117
6. Sugihara H, Yonemitsu N, Miyabara S, Toda S 1987 Proliferation of unilocular fat cells in the primary culture. J Lipid Res 28:1038-1045
7. Tang QQ, Otto TC, Lane MD 2003 Mitotic clonal expansion: a synchronous process required for adipogenesis. Proc Natl Acad Sci USA 100:44-49
8. Fajas L, Landsberg RL, Huss-Garcia Y, Sardet C, Lees JA, Auwerx J 2002 E2Fs regulate adipocyte differentiation. Dev Cell 3:39-49
9. Abella A, Dubus P, Malumbres M, Rane SG, Kiyokawa H, Sicard A, Vignon F, Langin D, Barbacid M, Fajas L 2005 Cdk4 promotes adipogenesis through PPARγ activation. Cell Metab 2:239-249
10. Sarruf DA, Iankova I, Abella A, Assou S, Miard S, Fajas L 2005 Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor γ. Mol Cell Biol 25:9985-9995
11. Tontonoz P, Hu E, Spiegelman BM 1994 Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147-1156
12. Freytag SO, Paielli DL, Gilbert JD 1994 Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 8:1654-1663
13. Cao Z, Umek RM, McKnight SL 1991 Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552
14. Yeh WC, Cao Z, Classon M, McKnight SL 1995 Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 9:168-181
15. Bloom BR, Bennett B 1966 Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80-82
16. David JR 1966 Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56:72-77
17. Weiser WY, Temple PA, Witek-Giannotti JS, Remold HG, Clark SC, David JR 1989 Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc Natl Acad Sci USA 86:7522-7526
18. Calandra T, Roger T 2003 Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791-800
19. Nemajerova A, Moll UM, Petrenko O, Fingerle-Rowson G 2007 Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle. Cell Cycle 6:1030-1034
20. Nishihira J, Ishibashi T, Fukushima T, Sun B, Sato Y, Todo S 2003 Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. Ann NY Acad Sci 995:171-182
21. Thiele M, Bernhagen J 2005 Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxid Redox Signal 7:1234-1248
22. Mitchell RA 2004 Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16:13-19
23. Dandona P, Aljada A, Ghanim H, Mohanty P, Tripathy C, Hofmeyer D, Chaudhuri A 2004 Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J Clin Endocrinol Metab 89:5043-5047
24. Church TS, Willis MS, Priest EL, Lamonte MJ, Earnest CP, Wilkinson WJ, Wilson DA, Giroir BP 2005 Obesity, macrophage migration inhibitory factor, and weight loss. Int J Obes 29:675-681
25. Sakaue S, Ishimaru S, Hizawa N, Ohtsuka Y, Tsujino I, Honda T, Suzuki J, Kawakami Y, Nishihira J, Nishimura M 2006 Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity. Int J Obes 30:238-242
26. Hirokawa J, Sakaue S, Tagami S, Kawakami Y, Sakai M, Nishi S, Nishihira J 1997 Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-α. Biochem Biophys Res Commun 235:94-98
27. Hirokawa J, Sakaue S, Furuya Y, Ishii J, Hasegawa A, Tagami S, Kawakami Y, Sakai M, Nishi S, Nishihira J 1998 Tumor necrosis factor-α regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes. J Biochem 123:733-739
28. Student AK, Hsu RY, Lane MD 1980 Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem 255:4745-4750
29. Sun B, Nishihira J, Yoshiki T, Kondo M, Sato Y, Sasaki F, Todo S 2005 Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. Clin Cancer Res 11:1050-1058
30. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, Mukai M 2000 Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5:397-403
31. Nishihira J, Kuriyama T, Sakai M, Nishi S, Ohki S, Hikichi K 1995 The structure and physicochemical properties of rat liver macrophage migration inhibitory factor. Biochim Biophys Acta 1247:159-162
32. Suzuki H, Kanagawa H, Nishihira J 1996 Evidence for the presence of macrophage migration inhibitory factor in murine reproductive organs and early embryos. Immunol Lett 51:141-147
33. Hogan JC, Stephens JM 2005 Effects of leukemia inhibitory factor on 3T3-L1 adipocytes. J Endocrinol 185:485-496
34. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF 1995 A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746-26749
35. Lane MD, Tang QQ, Jiang MS 1999 Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation. Biochem Biophys Res Commun 266:677-683
36. Wu Z, Bucher NL, Farmer SR 1996 Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol Cell Biol 16:4128-4136
37. Christy RJ, Kaestner KH, Geiman DE, Lane MD 1991 CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 88:2593-2597
38. Clarke SL, Robinson CE, Gimble JM 1997 CAAT/enhancer binding proteins directly modulate transcription from the peroxisome proliferator-activated receptor γ2 promoter. Biochem Biophys Res Commun 240:99-103
39. Takahashi N, Nishihira J, Sato Y, Kondo M, Ogawa H, Ohshima T, Une Y, Todo S 1998 Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol Med 4:707-714
40. Liu L, Ji C, Chen J, Li Y, Fu X, Xie Y, Gu S, Mao Y 2008 A global genomic view of MIF knockdown-mediated cell cycle arrest. Cell Cycle 7:1678-1692
41. Tang QQ, Otto TC, Lane MD 2003 CCAAT/enhancer-binding protein β is required for mitotic clonal expansion during adipogenesis. Proc Natl Acad Sci USA 100:850-855
42. Zhang JW, Tang QQ, Vinson C, Lane MD 2004 Dominant-negative C/EBP disrupts mitotic clonal expansion and differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 101:43-47
43. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J, Delohery T, Chen Y, Mitchell RA, Bucala R 2003 MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467-1476
44. Kleemann R, Hausser A, Geiger G, Mischke R, Burger-Kentischer A, Flieger O, Johannes FJ, Roger T, Calandra T, Kapurniotu A, Grell M, Finkelmeier D, Brunner H, Bernhagen J 2000 Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature 408:211-216
45. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R 1995 MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377:68-71
46. Ohsumi J, Sakakibara S, Yamaguchi J, Miyadai K, Yoshioka S, Fujiwara T, Horikoshi H, Serizawa N 1994 Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulin-induced adipocyte differentiation in 3T3-L1 cells. Endocrinology 135:2279-2282
47. Atsumi T, Cho YR, Leng L, McDonald C, Yu T, Danton C, Hong EG, Mitchell RA, Metz C, Niwa H, Takeuchi J, Onodera S, Umino T, Yoshioka N, Koike T, Kim JK, Bucala R 2007 The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 179:5399-5406
48. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, Gerard C, David JR 1999 Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J Exp Med 189:341-346